Park Ha Biological Technology Co., Ltd.
For the period ended Nov 28, 2025. Filed Nov 28, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Nov 28, 2025 · Filed Nov 28, 2025
Use the contents to explore the available documents and sections.
Contents
Cover page
Show cover page
6-K 1 ea0266568-01.htm CURRENT REPORT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
Park Ha Biological Technology Co., Ltd.
(Exact name of registrant as specified in its charter)
901, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
2025 Extraordinary General Meeting
In connection with the 2025 extraordinary general meeting of Park Ha Biological Technology Co., Ltd., a Cayman Islands company (the “Company”), the Company hereby furnishes the following documents:
Exhibits
| Exhibit No. | Description |
| 99.1 | Notice of 2025 Extraordinary General Meeting, dated November 28, 2025, to be mailed to the shareholders of the Company |
| 99.2 | Form of Proxy Card to be mailed to the shareholders of the Company |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 28, 2025
| Park Ha Biological Technology Co., Ltd. | |
| By: | /s/ ZHANG Xiaoqiu |
| Name: | ZHANG Xiaoqiu |
| Title: | Chief Executive Officer andChairperson of the Board |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.